Mineralys Therapeutics, Inc. (MLYS)

NASDAQ: MLYS · IEX Real-Time Price · USD

13.20

-0.42 (-3.08%)

At close: Jul 19, 2024, 12:00 AM

13.28

+0.08 (0.61%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Mineralys Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	655	354	-	-	-
Market Cap Growth	0.14%	-	-	-	-
Enterprise Value	317	117	-110	-11	3
PE Ratio	-	-4.92	-	-	-
PB Ratio	2.00	1.47	-	-	-
P/FCF Ratio	-7.31	-4.35	-	-	-
P/OCF Ratio	-7.32	-4.35	-	-	-
EV/EBITDA Ratio	-3.33	-1.63	3.70	0.55	-0.93
EV/EBIT Ratio	-3.33	-1.63	3.70	0.55	-0.93
EV/FCF Ratio	-3.45	-1.44	3.77	0.73	-1.25
Debt / Equity Ratio	-	-	-	-	-1.25
Debt / EBITDA Ratio	-	-	-	-	-1.36
Debt / FCF Ratio	-	-	-	-	-1.83
Quick Ratio	17.63	22.57	13.65	2.10	0.28
Current Ratio	18.06	23.77	13.98	2.20	0.29
Interest Coverage	-	-	-	-	-28.79
Return on Equity (ROE)	-32.50%	-26.50%	79.30%	146.40%	-
Return on Assets (ROA)	-31.10%	-25.50%	-47.50%	-307.80%	-
Return on Capital (ROIC)	-32.03%	-35.10%	60.22%	81.68%	-325.91%
Earnings Yield	-13.85%	-20.34%	-	-	-
FCF Yield	-13.37%	-22.96%	-	-	-
Buyback Yield / Dilution	-81.31%	-600.33%	-3.67%	90.03%	-
Total Shareholder Return	-81.31%	-600.33%	-3.67%	90.03%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).